BIODEL INC's ticker is BIOD and the CUSIP is 09064M204. A total of 33 filers reported holding BIODEL INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $7,000 | +40.0% | 16,934 | -0.5% | 0.00% | – |
| Q2 2016 | $5,000 | -28.6% | 17,021 | -19.4% | 0.00% | – |
| Q1 2016 | $7,000 | -12.5% | 21,107 | -12.9% | 0.00% | – |
| Q4 2015 | $8,000 | -94.2% | 24,226 | -92.2% | 0.00% | – |
| Q3 2015 | $137,000 | -57.5% | 311,998 | -0.2% | 0.00% | – |
| Q2 2015 | $322,000 | +97.5% | 312,524 | +128.2% | 0.00% | – |
| Q1 2015 | $163,000 | -45.1% | 136,961 | -38.6% | 0.00% | – |
| Q4 2014 | $297,000 | -20.2% | 223,021 | +0.0% | 0.00% | – |
| Q3 2014 | $372,000 | -23.5% | 222,979 | -1.0% | 0.00% | – |
| Q2 2014 | $486,000 | +53.8% | 225,134 | +94.5% | 0.00% | – |
| Q1 2014 | $316,000 | +22.0% | 115,723 | +1.9% | 0.00% | – |
| Q4 2013 | $259,000 | -81.4% | 113,611 | -74.3% | 0.00% | – |
| Q3 2013 | $1,391,000 | -48.4% | 441,453 | -31.5% | 0.00% | -100.0% |
| Q2 2013 | $2,694,000 | +29.0% | 644,268 | -27.5% | 0.00% | – |
| Q4 2012 | $2,088,000 | +40.5% | 888,808 | +77.7% | 0.00% | – |
| Q3 2012 | $1,486,000 | – | 500,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST NEW YORK SECURITIES LLC /NY | 271,234 | $452,961,000 | 0.32% |
| Broadfin Capital, LLC | 1,330,034 | $2,221,000 | 0.23% |
| FNY Managed Accounts LLC | 32,000 | $53,440,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 1,492,803 | $2,493,000 | 0.10% |
| Rotella Capital Management, Inc. | 29,224 | $49,000 | 0.05% |
| SHEPHERD KAPLAN KROCHUK, LLC | 65,225 | $109,000 | 0.01% |
| Orbimed Advisors | 209,700 | $350,000 | 0.00% |
| First Allied Advisory Services, Inc. | 20,000 | $33,000 | 0.00% |
| TFS CAPITAL LLC | 14,017 | $23,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 1,470 | $2,000 | 0.00% |